Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000614166 | SCV000711966 | uncertain significance | not specified | 2016-06-28 | criteria provided, single submitter | clinical testing | The p.Met1403Val variant in OTOGL has been previously identified by our laborato ry in the heterozygous state in two siblings with hearing loss due to an alterna te genetic cause in another gene and a variant affecting the remaining copy of O TOGL has not bee identified. This variant has been identified in 0.24% (26/10930 ) of Latino chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs774172292). Although this variant has been seen in th e general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analysis suggests that the variant may impact the protein, though this information is not predictive enoug h to determine pathogenicity. In summary, the clinical significance of the p.Met 1403Val variant is uncertain. |
Baylor Genetics | RCV001334655 | SCV001527561 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 84B | 2018-01-01 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV001662647 | SCV001873626 | uncertain significance | not provided | 2022-12-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Invitae | RCV001662647 | SCV003258326 | likely benign | not provided | 2023-10-07 | criteria provided, single submitter | clinical testing |